Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
15
APLT Quote, Financials, Valuation and Earnings
Last price:
$0.22
Seasonality move
:
28.77%
Day range:
$0.22 - $0.23
52-week range:
$0.20 - $1.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
30.84x
P/B ratio:
1.80x
Volume:
5.9M
Avg. volume:
18.4M
1-year change:
-83.21%
Market cap:
$31.3M
Revenue:
$455K
EPS (TTM):
-$0.10
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
APLT
Applied Therapeutics, Inc.
|
$250K | -$0.14 | 104.92% | -70.54% | $1.33 |
|
AMIX
Autonomix Medical, Inc.
|
-- | -- | -- | -- | $6.60 |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
SVRA
Savara, Inc.
|
-- | -$0.13 | -- | -13.45% | $10.31 |
|
TMCI
Treace Medical Concepts, Inc.
|
$49.7M | -$0.27 | -10.11% | -1650% | $6.56 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
APLT
Applied Therapeutics, Inc.
|
$0.22 | $1.33 | $31.3M | -- | $0.00 | 0% | 30.84x |
|
AMIX
Autonomix Medical, Inc.
|
$0.85 | $6.60 | $5.8M | -- | $0.00 | 0% | -- |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$1.21 | $0.85 | $152.5M | 2.03x | $0.80 | 0% | 2.35x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
SVRA
Savara, Inc.
|
$6.50 | $10.31 | $1.3B | -- | $0.00 | 0% | -- |
|
TMCI
Treace Medical Concepts, Inc.
|
$2.74 | $6.56 | $174.6M | -- | $0.00 | 0% | 0.79x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
APLT
Applied Therapeutics, Inc.
|
128.93% | 3.416 | 2.86% | 0.36x |
|
AMIX
Autonomix Medical, Inc.
|
-- | 0.300 | -- | 5.03x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | 2.113 | 8.08% | 1.85x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
SVRA
Savara, Inc.
|
24.02% | -1.594 | 4.83% | 7.42x |
|
TMCI
Treace Medical Concepts, Inc.
|
44.1% | 1.305 | 16.46% | 2.25x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
APLT
Applied Therapeutics, Inc.
|
$889K | -$16.8M | -70.3% | -77.88% | -1675.8% | -$18.4M |
|
AMIX
Autonomix Medical, Inc.
|
-$2K | -$7.5M | -228.46% | -243.23% | -- | -$3.8M |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
SVRA
Savara, Inc.
|
-$76K | -$30.3M | -65.99% | -78.83% | -- | -$22.5M |
|
TMCI
Treace Medical Concepts, Inc.
|
$39.7M | -$15.7M | -29.15% | -49.13% | -31.22% | -$11.9M |
Applied Therapeutics, Inc. vs. Competitors
-
Which has Higher Returns APLT or AMIX?
Autonomix Medical, Inc. has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of --. Applied Therapeutics, Inc.'s return on equity of -77.88% beat Autonomix Medical, Inc.'s return on equity of -243.23%.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M AMIXAutonomix Medical, Inc.-- -$1.38 $6.4M -
What do Analysts Say About APLT or AMIX?
Applied Therapeutics, Inc. has a consensus price target of $1.33, signalling upside risk potential of 515.57%. On the other hand Autonomix Medical, Inc. has an analysts' consensus of $6.60 which suggests that it could grow by 681.07%. Given that Autonomix Medical, Inc. has higher upside potential than Applied Therapeutics, Inc., analysts believe Autonomix Medical, Inc. is more attractive than Applied Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.1 3 0 AMIXAutonomix Medical, Inc.1 0 0 -
Is APLT or AMIX More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison Autonomix Medical, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock APLT or AMIX?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Autonomix Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. Autonomix Medical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or AMIX?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than Autonomix Medical, Inc. quarterly revenues of --. Applied Therapeutics, Inc.'s net income of -$19M is lower than Autonomix Medical, Inc.'s net income of -$7.5M. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while Autonomix Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 30.84x versus -- for Autonomix Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.30.84x -- $1M -$19M AMIXAutonomix Medical, Inc.-- -- -- -$7.5M
-
Which has Higher Returns APLT or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of -255.85%. Applied Therapeutics, Inc.'s return on equity of -77.88% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About APLT or NBY?
Applied Therapeutics, Inc. has a consensus price target of $1.33, signalling upside risk potential of 515.57%. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -29.75%. Given that Applied Therapeutics, Inc. has higher upside potential than NovaBay Pharmaceuticals, Inc., analysts believe Applied Therapeutics, Inc. is more attractive than NovaBay Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.1 3 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is APLT or NBY More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.103%.
-
Which is a Better Dividend Stock APLT or NBY?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or NBY?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. Applied Therapeutics, Inc.'s net income of -$19M is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while NovaBay Pharmaceuticals, Inc.'s PE ratio is 2.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 30.84x versus 2.35x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.30.84x -- $1M -$19M NBYNovaBay Pharmaceuticals, Inc.2.35x 2.03x $521K -$1.3M
-
Which has Higher Returns APLT or PTN?
Palatin Technologies has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of --. Applied Therapeutics, Inc.'s return on equity of -77.88% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M PTNPalatin Technologies-- -- -- -
What do Analysts Say About APLT or PTN?
Applied Therapeutics, Inc. has a consensus price target of $1.33, signalling upside risk potential of 515.57%. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than Applied Therapeutics, Inc., analysts believe Palatin Technologies is more attractive than Applied Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.1 3 0 PTNPalatin Technologies0 0 0 -
Is APLT or PTN More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock APLT or PTN?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or PTN?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than Palatin Technologies quarterly revenues of --. Applied Therapeutics, Inc.'s net income of -$19M is higher than Palatin Technologies's net income of --. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 30.84x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.30.84x -- $1M -$19M PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns APLT or SVRA?
Savara, Inc. has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of --. Applied Therapeutics, Inc.'s return on equity of -77.88% beat Savara, Inc.'s return on equity of -78.83%.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M SVRASavara, Inc.-- -$0.14 $124.2M -
What do Analysts Say About APLT or SVRA?
Applied Therapeutics, Inc. has a consensus price target of $1.33, signalling upside risk potential of 515.57%. On the other hand Savara, Inc. has an analysts' consensus of $10.31 which suggests that it could grow by 58.65%. Given that Applied Therapeutics, Inc. has higher upside potential than Savara, Inc., analysts believe Applied Therapeutics, Inc. is more attractive than Savara, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.1 3 0 SVRASavara, Inc.6 0 0 -
Is APLT or SVRA More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison Savara, Inc. has a beta of 0.226, suggesting its less volatile than the S&P 500 by 77.376%.
-
Which is a Better Dividend Stock APLT or SVRA?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Savara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. Savara, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or SVRA?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are larger than Savara, Inc. quarterly revenues of --. Applied Therapeutics, Inc.'s net income of -$19M is higher than Savara, Inc.'s net income of -$29.6M. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while Savara, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 30.84x versus -- for Savara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.30.84x -- $1M -$19M SVRASavara, Inc.-- -- -- -$29.6M
-
Which has Higher Returns APLT or TMCI?
Treace Medical Concepts, Inc. has a net margin of -1899% compared to Applied Therapeutics, Inc.'s net margin of -32.44%. Applied Therapeutics, Inc.'s return on equity of -77.88% beat Treace Medical Concepts, Inc.'s return on equity of -49.13%.
Company Gross Margin Earnings Per Share Invested Capital APLTApplied Therapeutics, Inc.88.9% -$0.13 $1.9M TMCITreace Medical Concepts, Inc.79.07% -$0.26 $159.6M -
What do Analysts Say About APLT or TMCI?
Applied Therapeutics, Inc. has a consensus price target of $1.33, signalling upside risk potential of 515.57%. On the other hand Treace Medical Concepts, Inc. has an analysts' consensus of $6.56 which suggests that it could grow by 99.64%. Given that Applied Therapeutics, Inc. has higher upside potential than Treace Medical Concepts, Inc., analysts believe Applied Therapeutics, Inc. is more attractive than Treace Medical Concepts, Inc..
Company Buy Ratings Hold Ratings Sell Ratings APLTApplied Therapeutics, Inc.1 3 0 TMCITreace Medical Concepts, Inc.2 3 0 -
Is APLT or TMCI More Risky?
Applied Therapeutics, Inc. has a beta of 1.989, which suggesting that the stock is 98.936% more volatile than S&P 500. In comparison Treace Medical Concepts, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock APLT or TMCI?
Applied Therapeutics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Treace Medical Concepts, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Applied Therapeutics, Inc. pays -- of its earnings as a dividend. Treace Medical Concepts, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios APLT or TMCI?
Applied Therapeutics, Inc. quarterly revenues are $1M, which are smaller than Treace Medical Concepts, Inc. quarterly revenues of $50.2M. Applied Therapeutics, Inc.'s net income of -$19M is lower than Treace Medical Concepts, Inc.'s net income of -$16.3M. Notably, Applied Therapeutics, Inc.'s price-to-earnings ratio is -- while Treace Medical Concepts, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Applied Therapeutics, Inc. is 30.84x versus 0.79x for Treace Medical Concepts, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income APLTApplied Therapeutics, Inc.30.84x -- $1M -$19M TMCITreace Medical Concepts, Inc.0.79x -- $50.2M -$16.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 48.08% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 6.66% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 6.48% over the past day.
